Journey Medical Corporation is a drug manufacturers - specialty & generic business based in the US. Journey Medical Corporation shares (DERM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.58 – an increase of 7.51% over the previous week. Journey Medical Corporation employs 41 staff and has a trailing 12-month revenue of around $57.8 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $5.58 |
|---|---|
| 52-week range | $2.85 - $6.89 |
| 50-day moving average | $4.54 |
| 200-day moving average | $5.01 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.92 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.58 from 2025-02-27
| 1 week (2025-02-21) | 7.51% |
|---|---|
| 1 month (2025-01-31) | 22.64% |
| 3 months (2024-11-29) | -3.46% |
| 6 months (2024-08-30) | 12.05% |
| 1 year (2024-03-01) | 35.11% |
|---|---|
| 2 years (2023-03-01) | 253.16% |
| 3 years (2022-03-01) | 13.18% |
| 5 years (2020-02-26) | N/A |
| Revenue TTM | $57.8 million |
|---|---|
| Gross profit TTM | $33.1 million |
| Return on assets TTM | -17.33% |
| Return on equity TTM | -129.58% |
| Profit margin | -31.74% |
| Book value | $0.53 |
| Market Capitalization | $116.6 million |
TTM: trailing 12 months
We're not expecting Journey Medical Corporation to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Journey Medical Corporation's shares have ranged in value from as little as $2.85 up to $6.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Journey Medical Corporation's is 1.038. This would suggest that Journey Medical Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Journey Medical Corporation's beta into context you can compare it against those of similar companies.
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Microsoft, IBM, IONQ, Rigetti and Quantum Computing are some of the top stocks to buy in this category. See how to get started here.
Learn how to invest in AI and capitalize on this rapidly growing industry.
Here are the best dividend stocks so far of the year based on dividend yield and analyst ratings.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Yes, you can trade penny stocks on Robinhood. Here are some of the top penny stocks to buy on Robinhood and how to get started.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
A deep dive into the highlights and limitations of Robinhood.